WisdomTree BioRevolution Fund Rating $17.78 +4.52 (+34.09%) Closing price 10/15/2025 03:47 PM EasternExtended Trading$17.79 +0.01 (+0.03%) As of 10/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.62Holdings in WDNA have an aggregate rating of Moderate Buy based on 322 analyst ratings issued in the past year covering 23 companies (50.3% of the portfolio).WDNA Aggregate Price Target$17.78High Prediction$17.78Average Prediction$17.78Low Prediction$17.78Holdings in WDNA have an aggregate price target of $17.78 and a range of $17.78 to $17.78 covering 23 companies (50.3% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.02%NTLAIntellia Therapeutics$25.93+8.5%3.706 of 5 stars2.52$27.95 7.8%21Gap Up3.93%QUREuniQure$62.83+6.6%3.173 of 5 stars2.83$71.75 14.2%123.01%CRSPCRISPR Therapeutics$71.82+3.5%1.5294 of 5 stars2.42$71.71 -0.2%19Analyst ForecastInsider TradeGap Up2.64%ARCTArcturus Therapeutics$21.57+1.5%2.882 of 5 stars2.90$50.57 134.5%10News CoverageAnalyst UpgradeGap Down2.62%DNAGinkgo Bioworks$15.80+12.1%1.1855 of 5 stars1.67$9.00 -43.0%32.35%NTRANatera$179.42+3.8%2.3966 of 5 stars2.90$194.06 8.2%20Positive NewsAnalyst Forecast2.28%STOKStoke Therapeutics$35.60+1.9%3.0099 of 5 stars2.88$30.83 -13.4%8Analyst ForecastHigh Trading Volume2.20%UTHRUnited Therapeutics$432.19-0.3%4.3006 of 5 stars2.67$457.21 5.8%15Insider Trade2.19%BEAMBeam Therapeutics$27.19+7.0%3.1092 of 5 stars2.94$45.92 68.9%162.18%EDITEditas Medicine$4.06+13.1%4.2781 of 5 stars2.14$5.10 25.6%142.11%AGIOAgios Pharmaceuticals$41.38+2.8%4.4891 of 5 stars2.57$57.25 38.4%72.06%SANASana Biotechnology$5.92+33.0%3.0209 of 5 stars2.75$7.50 26.7%8News CoverageTrading HaltedHigh Trading Volume1.99%RGNXREGENXBIO$12.30+9.3%4.3972 of 5 stars2.57$28.38 130.7%71.99%IONSIonis Pharmaceuticals$72.39+1.4%3.3435 of 5 stars2.80$78.28 8.1%201.94%VCYTVeracyte$34.78+2.4%3.6837 of 5 stars2.67$40.90 17.6%121.91%LLYEli Lilly and Company$826.20+1.7%4.9964 of 5 stars2.68$948.06 14.7%25Trending NewsAnalyst UpgradeAnalyst Revision1.75%GILDGilead Sciences$118.30-0.2%4.8789 of 5 stars2.86$118.08 -0.2%29Positive News1.69%TXG10x Genomics$11.89+3.0%3.9169 of 5 stars2.38$13.65 14.8%16Analyst Forecast1.63%TEMTempus AI$91.91+2.3%1.6217 of 5 stars2.43$71.83 -21.8%14Gap Up1.52%TWSTTwist Bioscience$32.04+4.9%3.8111 of 5 stars2.58$48.50 51.4%12Gap Up1.47%BNTXBioNTech$104.34+1.7%2.1698 of 5 stars2.64$134.32 28.7%14Analyst Forecast1.41%FOLDAmicus Therapeutics$8.37+4.1%4.4632 of 5 stars2.82$15.78 88.5%11Positive News1.39%GPCRStructure Therapeutics$29.23-3.0%3.2039 of 5 stars2.89$68.67 134.9%9Positive News This page (BATS:WDNA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
